Stay updated on ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Sign up to get notified when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.

Latest updates to the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page
- CheckyesterdayChange DetectedThe study record page now shows a 403 Forbidden error, replacing the study details with a generic site error page. The page displays a standard header and footer instead of the study content.SummaryDifference20%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page shows a new revision label (v3.6.6) replacing the previous v3.6.5, indicating an internal update to the page template or platform.SummaryDifference0.1%

- Check43 days agoChange DetectedFooter now displays Revision: v3.6.5, indicating a recent minor update to the page template or CMS of the study record. This version bump updates the versioning label but does not modify the clinical trial details shown on the page.SummaryDifference0.0%

- Check57 days agoChange DetectedThe page's revision indicator was updated from v3.6.3 to v3.6.4. This suggests a minor update to the page's platform or styling without changing the study details.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page’s revision label was updated from v3.6.2 to v3.6.3. This indicates a small site update and does not change study content or user-facing information.SummaryDifference0.0%

- Check86 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2 on the page, indicating a newer release of the page. This is a metadata update and does not modify the study content or results.SummaryDifference0.0%

Stay in the know with updates to ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ACI-24 Vaccine Safety in Down Syndrome Adults Clinical Trial page.